Velcade 3.5 MG vials
Ended Awarded
- Contract number
- SPE2DB23FYQ83
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,861
Award facts
- Contract value 100% obligated
- $6,860.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $6,860.58 and has an ultimate completion date of September 11, 2023. It is a firm fixed-price contract for the delivery of 3.5 mg Velcade vials, a cancer medication.
This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group provides a vast array of medications, including both common and specialized pharmaceutical products, to support the diverse medical needs of military personnel and their dependents across various Department of Defense (DoD) healthcare facilities.
The contract has no set-aside designation, as DMS Pharmaceutical Group's status as a woman-owned small business has enabled it to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.
Quick answers
Who was awarded contract SPE2DB23FYQ83?
SPE2DB23FYQ83 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 18, 2023.
How much is contract SPE2DB23FYQ83 worth?
The government has obligated $6,861 on SPE2DB23FYQ83.
Is contract SPE2DB23FYQ83 an order under another contract?
Yes. SPE2DB23FYQ83 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB23FYQ83 competed?
The extent of competition for SPE2DB23FYQ83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award